Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Sunitinib × Clear all

NCT00392496 2014-05-15

Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma

Phase 2 Completed

19 enrolled 4 charts

Lymphoma, Large B-Cell, Diffuse